title: Expression of microRNAs: potential molecular link between obesity, diabetes and cancer.
abstract: Clinicians are routinely challenged in their management of cancer patients because of the complexities of obesity and diabetes that are often found as comorbid conditions. Although attention has been given to optimizing treatment planning for these patients, less attention has been given to manage their obesity and diabetes. This suggests that newer, comprehensive approaches must be developed for the treatment of cancer patients as a 'whole' rather than as a single disease. While the specific pathologies of each are unique, years of research have indicated intimate molecular links between these chronic diseases. The contribution of sedentary lifestyles and poor dietary habits is recognized; however, the precise molecular links are still not well-explored. In addition, emerging evidence suggests the important role of microRNAs (miRNAs) in the development and progression of several diseases, yet their roles in linking obesity, diabetes and cancer are only now beginning to be recognized. It is hoped that miRNAs will serve as novel biomarkers and molecular targets for cancer therapy in patients with comorbid conditions. In this review, we discuss the current understanding of the pathobiology of obesity, diabetes and cancer, and document molecular roles of miRNAs linking cancer with obesity and diabetes.
authors.affiliation: Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Ali
authors.forename: S
authors.initials: S
authors.lastname: Ali
authors.forename: A
authors.initials: A
authors.lastname: Ahmad
authors.forename: B
authors.initials: B
authors.lastname: Bao
authors.forename: P A
authors.initials: PA
authors.lastname: Philip
authors.forename: F H
authors.initials: FH
authors.lastname: Sarkar
mesh_terms: D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy; D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D005819:Genetic Markers; D015316:Genetic Therapy; D006801:Humans; D035683:MicroRNAs / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009369:Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy; D009765:Obesity / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy
chemical_list: D005819:Genetic Markers; D035683:MicroRNAs